Patients With Kidney Cancer in Stages III and IV May Benefit from the Cancer Vaccination
Surgery to remove the tumor is the standard of care for individuals with stage III or IV clear cell renal cell carcinoma.
Category: Oncology
An International Study Reveals That a Breakthrough in Childhood Brain Cancer Research Could Revolutionize Treatment
In preclinical models tested in mice, a possible novel targeted therapy for children brain cancer has been found to be successful in infiltrating and destroying tumor cells
Key to Immunotherapy: A Computer Model Assists in Identifying Immune Cells That Fight Cancer
PD-1 inhibitors and other immune checkpoint inhibitors can be used to treat dozens of different forms of cancer.
A New Study Reveals the Secret to a Sustained Immune Response in Cancer and Chronic Illnesses
The study discovered that the body may produce more ID3+ T cells in response to certain signals, opening the door for better therapies like CAR T cell therapy.
Research Proves AI Boosts Efficacy of Cancer Treatment
Physicians were required to decide on cancer patients’ treatments, initially without the aid of technology and later with AI’s support.
Recent Research Identified that Risk of Cancer Established Before Birth
As people age, their risk of developing cancer rises due to a build-up of DNA damage and other factors. However, not all aberrant cells develop into cancer.
Research discovered gene expression regulation in cancer and cellular functions
The interdisciplinary research team headed by Professors Seyun Kim, Gwangrog Lee, and Won-Ki Cho from the Department of Biological Sciences revealed crucial mechanisms regulating gene expression in animal cells on January 22, according to KAIST.
Combination of chemotherapy and dual-targeted treatments Phase III Breakwater Clinical trials supported for BRAF-mutated metastatic colorectal cancer FDA approval
Data from this 28-country multi-institutional effort helped the Food and Drug Administration (FDA) approve this combination more quickly in December 2024, giving patients with BRAF V600E-mutant mCRC a new and effective first-line treatment choice.
How the molecular dynamics of CAR T cells influence their ability to cancer-killing behavior
In order to build the groundwork for creating CAR molecules that optimize antitumor activity beyond B cell malignancies, researchers set out to comprehend how CAR T cells with various signaling domains function at the molecular and cellular levels.
Researchers Reveal Alarming Variations in a Key Cancer Immunotherapy Target Between Humans and Mice
Scientists created new medications to suppress PD-1 and activate the body’s immune system to combat cancer after its discovery.
